AstraZeneca says antibody treatment failed in preventing Covid-19 in exposed patients

AZD7442 reduced the risk of developing symptomatic Covid-19 by 33% compared to a placebo

Comments

Popular posts from this blog

Bengaluru: Bus conductor fails to return Rs 1; court orders BMTC to pay Rs 3K as compensation

Karnataka court issues summons to Yediyurappa in POCSO case

MUDA case: Karnataka HC rejects Siddaramaiah’s plea against Governor move